Diagnosis and Monitoring of Osteoporosis with Total-Body 18F-Sodium Fluoride-PET/CT

PET Clin. 2020 Oct;15(4):487-496. doi: 10.1016/j.cpet.2020.06.011. Epub 2020 Aug 4.

Abstract

In recent years, 18F-Sodium Fluoride (NaF)-PET/CT has seen its role in the detection and management of osteoporosis increase. This article reviews the extent of this application in the literature, its efficacy compared with other comparable imaging tools, and how total-body PET/CT combined with global disease assessment can revolutionize measurement of total osteoporotic disease activity. NaF-PET/CT eventually can be the modality of choice for metabolic bone disorders, especially with these advances in technology and computation.

Keywords: Global Disease Assessment; NaF; Osteoporosis; PET/CT; Total-body PET/CT.

Publication types

  • Review

MeSH terms

  • Bone and Bones / diagnostic imaging
  • Fluorine Radioisotopes*
  • Humans
  • Osteoporosis / diagnostic imaging*
  • Positron Emission Tomography Computed Tomography / methods*
  • Sodium Fluoride*
  • Whole Body Imaging / methods*

Substances

  • Fluorine Radioisotopes
  • Sodium Fluoride
  • Fluorine-18